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Abstract
Introduction: Retinoprotective effects of non-selective imidazoline receptor agonists: potassium salt of С7070; so-
dium salt of С7070; С7070 processed with CO2 – were investigated in comparison with C7070 on the retinal isch-
emia-reperfusion model in rats.
Materials and methods: The protective effects of the substances were evaluated by using ophthalmoscopy, laser Dop-
pler flowmetry, electroretinography, histological and morphometric studies of retinal layers.
Results and discussion: The most pronounced retinoprotective effect was observed in potassium salt of C7070 at a 
dose of 10 mg/kg, which expresses in approaching the normal eye fundus image, achieving the target values of the 
retinal blood flow, b/a coefficient, and reaching the norm values of morphometric indicators. A less pronounced protec-
tive effect was found in sodium salt of C7070 at a dose of 10 mg/kg, which expresses in a 71% decrease (p < 0.05) in 
semi-quantitative assessment of the eye fundus changes, an increase in the retinal blood flow level by 70.4% (p < 0.05), 
in b/a by 94% (p < 0.05) in comparison with the group without correction, and reaching the norm of the morphometric 
indicators. A retinoprotective effect of the substance C7070 processed with CO2 at a dose of 10 mg/kg is inferior to that 
of the sodium salt of C7070.
Conclusion: The retinoprotective activity of the substances is expressed in descending order: potassium salt of С7070 
(10 mg/kg) ≈ С7070 (50 mg/kg) > sodium salt of С7070 (10 mg/kg) > С7070 processed with CO2 (10 mg/kg) ≈ С7070 
(10 mg/kg). Injections of glibenclamide leveled the neuroretinoprotective effects of the substances to varying degrees, 
which confirmed the participation of ATP-dependent potassium channels in the implementation of these effects.
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Introduction
Retinal ischemia may have various etiologies: central re-
tinal artery (CRA) occlusion and occlusion of its bran-
ches, atherosclerosis of retinal vessels, of carotid arte-
ries, glaucoma with normal intraocular pressure (IOP), 
endocrine ophthalmopathy, surgical operations, etc. CRA 
occlusion is observed in 57% of cases, occlusion of its 
branches – in 38%. Acute occlusions of retinal arteries in 
91.2% of cases occur against the background of cardio-
vascular system diseases. Nonarteritic anterior ischemic 
optic neuropathy (NAION), acute ischemia of the anteri-
or segment of the optic nerve, occurs 6 times more often 
compared with neuropathy developed against the back-
ground of systemic vasculitis. The prevalence of the di-
sease is 2.3–10.2 per 100,000 population over 50 years of 
age (Avetisov et al. 2018).
Retinal ischemia leads to inhibition of metabolic pro-
cesses in its layers with retinal cell apoptosis (Hayreh 
2013, Janáky et al. 2007, Ju et al. 2018). At the heart of is-
chemic neuropathy of the optic nerve is an acute disorder 
of arterial blood circulation in the system of vessels feed-
ing the optic nerve. In the development of this pathology, 
a leading role is played by biochemical, haemodynamic 
and haemostatic disorders that develop in atherosclero-
sis, hypertension, diabetes mellitus, blood diseases, and 
arterial (brachiocephalic, etc.) occlusions (Hayreh 2013).
Currently, there is no unique and effective treatment 
for NAION, despite the fact that it is a major pathology 
that affects the optic nerve in the elderly and often leads 
to a significant loss of visual acuity (Nuzzi and Monteu 
2017, Wilhelm et al. 2015).
Type II imidazoline receptors are a new biological tar-
get for the treatment of neurological disorders (Li 2017). 
Type II imidazoline receptors are widely distributed in the 
brain, and their ligands may have therapeutic potential 
as neuroprotectors (Abás et al. 2017, Head and Mayorov 
2006). Activation of central type I imidazoline receptors 
leads to a decrease in blood pressure, due to the suppres-
sive impact on the peripheral sympathetic nervous system, 
which is reasonable when correcting hypertensive chang-
es in the retina and optic nerve, hypertensive neuroretin-
opathy, where retinal ischemia plays an important role in 
the pathogenesis (Peresypkina et al. 2018). Type III im-
idazoline receptors perform their function by regulating 
the concentration of K+ and Ca2+ in cells and is associated 
with the activation of ATP-dependent potassium channels 
(Morgan and Chan 2001), which is expected to have a 
positive effect in the correction of ischemic conditions.
As previous studies showed, when evaluating the tim-
ing of the simulated retinal ischemia in rats based on the 
measurement of microcirculation, electroretinography 
(ERG) and morphometric studies, 30-minute ischemia 
with subsequent reperfusion turned out to be the most 
optimal simulated ischemia (Shabelnikova et al. 2016). 
This model was applied in the present study to examine 
the possibilities of correcting retinal ischemic injuries by 
using imidazoline receptor agonists.
The substance C7070 is lipophilic (Buzov et al. 2016). 
At a dose of 50 mg/kg, the neuroprotective activity of 
C7070 is more pronounced in retinal pathology mod-
els than at a dose of 10 mg/kg. The dose of 50 mg/kg of 
C7070 in rats equals 628 mg for a man weighing 70 kg, 
which exceeds the minimum therapeutic dose for an adult 
by 6.28 times (Dovgan 2017). In this regard, the study of 
hydrophilic derivatives of C7070 with presumed higher 
bioavailability, namely potassium salt of С7070 with lab-
oratory code K+C7070, sodium salt of С7070 with labo-
ratory code Na+C7070, C7070 processed with carbon di-
oxide, with laboratory code С7070СО2 looks promising.
Due to the above, it is important to study the possi-
bilities of pharmacological correction of retinal ischemic 
injuries by using non-selective imidazoline receptor ago-
nists in the experiment.
Objective: to improve the efficacy of pharmacological 
correction of retinal ischemic injuries in the experiment 
by using non-selective imidazoline receptor agonists.
Materials and methods
The experiments were performed on white Wistar rats, 
males and females weighing 250 ± 25 g, with no external 
signs of the disease, which had passed quarantine. During 
the experiment, the rats were kept in a standard experi-
mental biologically clean room, the air temperature was 
22–24 °C, with a 12 h/12 h light/dark cycle; all the animals 
received granular feed and filtered water. Operations and 
other manipulations on the rats were carried out under ge-
neral anesthesia by intraperitoneal (i/p) injection of chloral 
hydrate solution at a dose of 300 mg/kg. The withdrawal 
of the animals from the experiment was carried out in ac-
cordance with the European Convention for the Protection 
of Vertebrate Animals Used for Experimental and Other 
Scientific Purposes adopted by the Council of Europe 
(Strasbourg, France, 1986) and Council Directive 86/609/
EEC of 24.11.1986 on the protection of animals used for 
experimental and other scientific purposes, with an over-
dose of chloral hydrate administered i/p. The animals were 
divided into groups by stratified randomization with stra-
tification by body weight, conditions of maintenance and 
nutrition, age, as well as by operations and manipulations.
Retinal Ischemia-reperfusion simulation
Retinal ischemia was simulated by increasing IOP to 
110 mm Hg by mechanical pressure on the anterior eye 
chamber for 30 minutes. Prio to that, IOP had been regis-
tered in the animals by introducing into the anterior cham-
ber a 30G needle of TSD104A sensor (МР150, BIOPAC 
SYSTEMS, Inc., Goleta, CA, USA). Rendering mechani-
cal pressure on the anterior chamber was carried out ba-
sing on a step of the cylinder calibration system, with the 
registration of an increase in IOP, which made it possible 
to estimate the level of IOP increase at a certain position. 
In this paper, this model of pathology was used, followed 
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by a 72-hour reperfusion episode in order to assess the 
retinoprotective effects of non-selective imidazoline re-
ceptor agonists.
Semi-quantitative assessment of changes in the eye 
fundus
To study the fundus in the laboratory rats, ophthalmosco-
py was used after 72 hours of reperfusion by using a Bx 
a Neitz Ophthalmoscope (Japan). For drug-induced my-
driasis, eye drops with phenylephrine (Irifrin 2.5%, PRO-
MED EXPORTS, India) were used by instillation into the 
conjunctival sac.
Doses were calculated using the dose conversion 
factor from an adult to rats weighing 250 g, according 
to the guidelines contained in the Guideline for Preclini-
cal Studies of Drugs. For adults, a single instillation of a 
2.5% solution is used during ophthalmoscopy. To create 
mydriasis, it is enough to inject 1 drop of 2.5% Irifrin 
into the conjunctival sac. One eye drop of 2.5% Irifrin 
contains 0.05 ml of the active substance. The conversion 
factor for an adult weighing 70 kg is 39. For rats weighing 
250 g, the conversion factor is 7.0. Thus, the calculated 
dose (CD) of Irifrin is (Formula 1):





A solution of eye drops was injected into the conjuncti-
val sac by using a micropipette in conversion to the body 
weight of rats. After the pupil was fully dilated, the oph-
thalmoscope was brought closer to the rat’s eye, with a 
beam of light directed at it from a distance of 0.5–2 cm 
to obtain a clear image of the retina. In case an image of 
the fundus was unclear, a lens to render clear images of 
the details of the fundus was selected by turning the disk 
of the ophthalmoscope. An OI-78M lens (VOLK Optical 
Inc, Mentor, OH, USA) was used to magnify and obtain 
images of the eye fundus.
For further statistical processing, the degree of chang-
es in the eye fundus during ophthalmoscopy against 
the background of simulating and correcting retinal is-
chemia-reperfusion was assessed in points (Table 1).
Evaluation of blood circulation in the retina using la-
ser Doppler flowmetry
Retinal blood flow in rats was measured by laser Dop-
pler flowmetry (LDF) 72 hours after simulating ischemia. 
The registration was carried out using MP-150 (BIOPAC 
Systems), a computer-based data acquisition system with 
software AcqKnowledge 4.2, and a TSD-144 needle pro-
be (USA). After the rats were anesthetized, a microcircu-
lation level was measured at 10 points on the circumfe-
rence of the eyeball; the recording of the microcirculation 
level readings at one point lasted for 20 seconds. From 
the microcirculation level results at every point, the mean 
value was calculated, which was taken as an indicator of 
the microcirculation level in the retina of the experimental 
animal. The value of microcirculation in the animal group 
was calculated as the average of the values obtained from 
each experimental animal in the group.
Assessment of the electrophysiological state of the re-
tina using ERG
A decrease in the amplitude of wave b is an indicator 
of ischemic retinal injury. ERG was performed imme-
diately after recording the microcirculation level. To 
perform ERG, the rats were kept in the dark for 30 min 
(Zahng et al. 2013), then anesthetized (chloral hydra-
te, 300 mg/kg of rat body weight, i/p). A corneal sil-
ver electrode was placed on the cornea pretreated with 
saline solution for better contact; a reference needle 
electrode EL452 (BIOPAC SYSTEMS, Inc., Goleta, 
CA, USA) was placed subcutaneously in the region 
of the skull, a ground needle electrode EL450 (BIO-
PAC SYSTEMS, Inc., Goleta, CA, USA) was placed 
subcutaneously at the base of the tail. A TSD122B 
stroboscope with a flash of white light connected to a 
STM200 stimulator (BIOPAC SYSTEMS, Inc., Goleta, 
CA, USA) was placed behind the animal’s back. The 
evoked biopotentials were transmitted at a frequency of 
1–1000 Hz, amplified, averaged, and presented graphi-
cally on the screen using the MP150 data acquisition 
and analysis system (BIOPAC SYSTEMS, Inc., Goleta, 
CA, USA) with ACQKNOWLEDGE 4.2. software. The 
ERG was recorded for 0.5 sec in each rat in the groups. 
To assess a degree of retinal ischemia, the ratio of the 
amplitudes of ERG b- and a-waves, a b/a coefficient, 
was evaluated (Sachidanandam et al. 2015). The mean 
was derived for each group from ten values received 
and was introduced into the protocol.
Table 1. Method of Integral Semi-quantitative Assessment of 
Changes in the Eye Fundus Caused by Simulating and Correcting 
Retinal Ischemia-Reperfusion by Pharmacological Agents, points.
Features of eye fundus changes observed during 
ophthalmoscopy
Score
Norm. The optic disc (OD) is round or oval, of pale pink 
colour against the fundus. The boundaries of OD are clear, 
located in the plane of the retina. The central retinal vessels 
emerge at the center of OD. Veins and arteries are rectilinear, 
their caliber is uniform, with no tortuosity. The overall 
background is pink.
0
Correction of neuronal injuries. The OD is round or oval, 
of pale pink colour against the background of the fundus. 
The OD has clear boundaries and is located in the plane of 
the retina. There is spasm of arteries (filamentous arteries), 
dilation and tortuosity of veins, and microaneurysms.
1
Correction of vascular injuries. Veins and arteries are 
rectilinear, of the uniform caliber, without tortuosity, 
microaneurysm or haemorrages. The OD is edematous, 
enlarged, and pale. The boundaries of OD are not clear.
2
Model of retinal ischemia-reperfusion. The OD is 
edematous, enlarged, and pale. The boundaries of OD are not 
clear. There is spasm of arteries (filamentous arteries), dilation 
and tortuosity of veins, microaneurysms., and hemorrhages. 
Retina is pale.
3
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Assessment of retinal changes using histological, 
morphometric studies
For a histological study, the eyes were removed with the 
adjacent tissues and fixed by immersion in a 10% forma-
lin solution. After fixing, the eyes were sectioned into two 
parts longitudinally through the centre, and both halves 
were processed into paraffin by routine methods. Serial 
sections were also made longitudinally, with a thickness 
of 5–7 μm, stained with haematoxylin and eosin. The sta-
ges of histological processing were performed using LEI-
CA equipment (Germany). For microscopy, morphome-
try and archiving, the prepared microslides were scanned 
using MIRAX DESK, a computerised archiving and 
image analysis system. Image analysis and morphome-
try were carried out by using a PANNORAMIC VIE-
WER 1.15.4. The thickness of the layers of the retina was 
measured in a strictly perpendicular direction to within 
onehundredth of a micrometre. In each animal, five re-
presentative areas, free from artifacts of treated material, 
were measured. The quantitative data were recorded in 
MS Excel spreadsheets.
Calculation of the specific number of neuronal nuclei 
in the inner nuclear layer was carried out by G. Avtan-
dilov point test on standard computer images obtained 
via a MIRAX DESK system for scanning and archiving 
images and PANNORAMIC VIEWER 1.15.4 software. 
A computer version of the 0.3 mm2 grid projected on the 
image was used.
In order to objectify the assessment of the detected 
qualitative changes in the retina, a degree of changes was 
recorded by conditional points: 0 points – no changes, 1 
point – minimal changes, 2 points – moderately expressed 
changes, 3 points – pronounced changes in neuronal 
structures. In each group, 30 retinal regions were eval-
uated, and the results were expressed as a “coefficient of 
change”, which was calculated by the formula 2:
(1 2 3 )
N
n n nCC × + × + ×=  (2)
where: n is the number of regions with the corresponding 
(0; 1; 2; 3) degree of change; N is the total number of 
regions studied.
Study design. Mode of administration and dose of 
pharmacological agents
Potassium salt of С7070 (potassium salt of 3-(1H-benzi-
midazol-2-il)-1,2,2-trimethyl cyclopentancarbonic acid, 
С16Н19КN2O2) with laboratory code K+C7070 (JSC Expe-
rimental Plant VladMiVa, Belgorod, Russia) was injec-
ted intragastrically (i/g) at a dose of 10 mg/kg as a single 
dose, 60 min before the retinal ischemia simulation in a 
1% starch solution.
Sodium salt of С7070 (sodium salt of 3-(1H-benzim-
idazol-2-il)-1,2,2-trimethyl cyclopentancarbonic acid, 
С16Н19NaN2O2) with laboratory code Na+C7070 (JSC Ex-
perimental Plant VladMiVa, Belgorod, Russia) was inject-
ed i/g at a dose of 10 mg/kg as a single dose, 60 min before 
the retinal ischemia simulation in a 1% starch solution.
С7070 processed with CO2, with laboratory code 
С7070СО2 (JSC Experimental Plant VladMiVa, Belgo-
rod, Russia) was injected i/g at a dose of 10 mg/kg as a 
single dose, 60 min before the retinal ischemia simulation 
in a 1% starch solution.
Substance with laboratory code C7070 (3-(1H-benzim-
idazole-2-il)-1,2,2-trimethyl cyclopentancarbonic acid) 
(JSC Experimental Plant VladMiVa, Belgorod, Russia) was 
injected i/g at doses of 10 mg/kg, 50 mg/kg as a single dose, 
60 min before the ischemia simulation in a 1% starch solu-
tion when correcting experimental retinal ischemia-reper-
fusion as a reference substance (Peresypkina 2018).
Glibenclamide, Maninil (Berlin-Chemie AG, Germa-
ny), a blocker of ATP-dependent potassium channels, was 
injected i/g at a dose of 5 mg/kg (Dowlatshahi et al. 2015, 
Mohamed et al. 2018, Peresypkina et al. 2017), once 60 
minutes before ischemia simulation to confirm the imple-
mentation of a retinoprotective action of the pharmaco-
logical agents through the activation of ATP-dependent 
potassium channels.
Evaluation of the effectiveness of the studied substances 
on the retinal ischemia-reperfusion model was performed 
after 72 hours of reperfusion, with the use of ophthalmos-
copy, integral semi-quantitative assessment of changes in 
the eye fundus, LDF, ERG and morphological studies.
The design of the experiment is presented in Table 2.
Statistical data processing
For all the data, descriptive statistics were used, and the 
data were checked for normal distribution. A distribution 
type was determined by using the Shapiro-Wilk criterion. 
In case of normal distribution, the mean value (M) and 
standard error of the mean (m) were calculated. Outliers 
at each time point were identified using a Grubbs statis-
Table 2. The research design of the protective effects of the im-
idazoline receptor agonists K+C7070, Na+C7070, С7070CO2 on 
the retinal Ischemia-reperfusion model.
Wistar rats (n=120). Weight 250 ± 25 g. Housing conditions: 
standard experimental biologically clean room. Illumination 12 
h/12 h light/dark cycle, t (22–24) °C
1. Intact (n = 10)
2. Simulated retinal ischemia-reperfusion (n = 10)
3. Correction by K+C7070, 10 mg/kg (n = 10)
4. Correction by Na+C7070, 10 mg/kg (n = 10)
5. Correction by С7070CO2, 10 mg/kg (n = 10)
6. Correction by С7070, 10 mg/kg (n = 10)
7. Correction by С7070, 50 mg/kg (n = 10)
8. Correction by K+C7070, 10 mg/kg + glibenclamide, 5 mg/kg (n = 10)
9. Correction by Na+C7070, 10 mg/kg + glibenclamide, 5 mg/kg (n = 10)
10. Correction by С7070CO2, 10 mg/kg + glibenclamide, 5 mg/kg 
(n = 10)
11. Correction by С7070, 10 mg/kg + glibenclamide, 5 mg/kg (n = 10)
12. Correction by С7070, 50 mg/kg + glibenclamide, 5 mg/kg (n = 10)
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tical test. If for any value, the value of Z exceeded the 
critical number of measurements N for this value, this ex-
periment was excluded from further calculations. In cases 
of abnormal distribution, the median (Me) and the quar-
tile range (QR) were calculated. Between-group differen-
ces were analyzed by parametric (t-Student criterion) or 
non-parametric (Mann-Whitney test) methods, depending 
on a distribution type. Differences were determined at a 
0.05 significance level. Statistical analyses were perfor-
med using Statistica 10.0 software.
Results and discussion
After 72 hours of reperfusion after an ischemic episode, 
in all the experimental groups the rats were anesthetized 
for the purpose of further studying the eye fundus image.
An example of the eye fundus image of a Wistar rat 
in the intact group is shown in Figure 1A and can be 
described as follows: OD is round or oval, of pale pink 
colour against the background of the fundus. The bound-
aries of OD are clear. OD is located in the plane of the 
retina; the retina is tightly attached over the entire area 
to the choroid. The central retinal vessels emerge at the 
center of OD. The retinal vessels have no anastomoses. 
The veins and arteries are rectilinear; their caliber is uni-
form, with no tortuosity. The overall background of the 
retina is pink.
The examples of the eye fundus images of the laborato-
ry rat with the simulated retinal ischemia-reperfusion are 
shown in Figure 1B, C and can be described as follows: 
OD is obviously decolorated, edemous and increased in 
size. The boundaries of OD are not clear. There arteries 
are stenosed; the veins are dilated; there are hemorrhages. 
The overall background of the retina is pale (ischemic).
The ophthalmoscopic image when correcting reti-
nal ischemia-reperfusion by means of potassium salt of 
C7070 at a dose of 10 mg/kg is shown in Figure 2A, and 
its description is close to normal: OD is round or oval, 
of pale pink colour against the background of the fun-
dus. The boundaries of OD are clear. OD is located in the 
plane of the retina. The veins and arteries are rectilinear; 
their caliber is uniform, with no tortuosity. The overall 
background of the retina is pink.
When sodium salt of С7070 was administered to the 
rats at a dose of 10 mg/kg to correct the simulated pa-
thology, the adjustment of the retinal vessels calibers was 
observed, but the veins remained plethoric; no microan-
eurysms were observed. The OD was slightly increased, 
pink. The boundaries of OD were clear (Fig. 2B).
When correcting retinal ischemic injury by means of 
С7070СО2 at a dose of 10 mg/kg, the ophthalmoscopic 
image in the group is as follows: the OD is slightly in-
creased, partly decolorized. The boundaries of the disk 
are clear. The veins are dilated, with sporadic microaneu-
rysms. The retina is pale (Fig. 2C).
The fundus image when administering С7070 as a ref-
erence drug at a dose of 10 mg/kg to the rats with simu-
lated retinal ischemia-reperfusion is shown in Figure 2D: 
OD is slightly increased, partly decolorized. The bounda-
ries of the disk are clear. The arteries are filamentous, the 
veins are plethoric. The retina is ischemic.
When administering C7070 at a dose of 50 mg/kg to 
the rats with simulated retinal ischemia-reperfusion, the 
fundus image is close to the norm and shown in Figure 2E.
In the experimental groups with the injection of gliben-
clamide to correct retinal ischemic injury by K+C7070 at 
a dose of 10 mg/kg and Na+C7070 at a dose of 10 mg/kg, 
a spasm of the retinal arteries is observed. The state of the 
OD is close to normal, similar to that in the groups with the 
injection of these substances. When administering gliben-
clamide in the groups with correction by С7070СО2 at a 
dose of 10 mg/kg, as well as by the reference substance 
C7070 at doses of 10 mg/kg and 50 mg/kg, the images of 
the eye fundus were not very different from a pathology 
model: obviously, edemous and decolorated OD; unclear 
boundaries of the OD, arterial spasm, plethoric veins, pale 
retina, microaneurysms and haemorrhages. Presumably, 
the blockade of ATP-dependent potassium channels by 
glibenclamide led to the elimination of the positive effects 
of these substances at the studied doses on the model of 
retinal ischemia-reperfusion.
Figure 1. Eye fundus images of Wistar rats: A – from intact group; B, C – with the simulated retinal ischemia-reperfusion.
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Figure 2. Eye fundus image of rats with correction of retinal ischemia-reperfusion by: A – potassium salt of С7070 at a dose of 
10 mg/kg, B – sodium salt of С7070 at a dose of 10 mg/kg, C – С7070 processed with CO2 at a dose of 10 mg/kg, D – С7070 at a 
dose of 10 mg/kg, E – С7070 at a dose of 50 mg/kg.
The results of the integral semi-quantitative assess-
ment of the changes in the eye fundus in the experimental 
groups are presented in Table 3.
Based on the obtained data of the integral semi-quan-
titative assessment of the changes in the eye fundus on 
the model of retinal ischemia-reperfusion in Wistar rats, it 
follows that the studied substances have the retinoprotec-
tive effect (in descending order): potassium salt of C7070 
(10 mg/kg) > C7070 (50 mg/kg) > sodium salt of C7070 
(10 mg/kg) > C7070 (10 mg/kg) > C7070CO2 (10 mg/kg).
The results of the LDF are presented in Table 4.
TBased on the obtained assessment data of the retinal mi-
crocirculation level in the experimental groups, it follows 
that the studied substances have a positive influence on 
the condition of retinal blood flow (in descending order): 
C7070 (50 mg/kg) > potassium salt of С7070 (10 mg/
kg) > sodium salt of С7070 (10 mg/kg) > C7070CO2 
(10 mg/kg) > C7070 (10 mg/kg).
The influence of the studied pharmacological agents on 
the amplitudes of a- and b-waves of electroretinograms ob-
tained in the experimental groups is presented in Table 5.
In each group, the b/a coefficient was calculated, the 
values of which are presented in Table 6.
When simulating retinal ischemia, after 72 hours of rep-
erfusion, the b/a coefficient decreased by 53% (p < 0.05) 
in comparison with the group of the intact animals. On 
the background of the injection of K+C7070 at a dose of 
10 mg/kg, as well as C7070 at a dose of 50 mg/kg, b/a 
significantly increased by more than 2 times in compar-
ison with the group without correction (p < 0.05). In the 
group with the injection of Na+C7070 at a dose of 10 mg/
kg, b/a increased by 94% in comparison with the value 
in the group without correction (p < 0.05). When inject-
ing C7070CO2 at a dose of 10 mg/kg to the animals, b/a 
in the group increased by 84% (p < 0.05), which is also 
significantly different from the mean in the group without 
correction. When correcting by means of C7070 at a dose 
of 10 mg/kg, b/a significantly increased by 68% (p < 0.05) 
in comparison with the group with pathology simulation.
Injection of glibenclamide in the groups with correc-
tion of pathology by K+C7070, Na+C7070, b/a increased 
by 68% and 52%, respectively, in comparison with the 
group with the simulated retinal ischemia-reperfusion, 
which indicated partial preservation of retinoprotective 
effects against the background of blockade of ATP-de-
pendent potassium channels. In the groups with correct-
ing retinal ischemic injury by means of С7070СО2 at a 
dose of 10 mg/kg; С7070 at a dose of 10 mg/kg; С7070 
at a dose of 50 mg/kg, the injection of glibenclamide pre-
vented the increase of the b/a coefficient.
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Thus, based on the obtained values of the amplitudes of 
b-wave and the b/a coefficient in the experimental groups, 
it follows that the studied substances have positive effects 
on the electrophysiological state of the retina when cor-
recting its ischemic injuries (in descending order): po-
tassium salt of С7070 (10 mg/kg), C7070 (50 mg/kg) > 
sodium salt of С7070 (10 mg/kg) > C7070CO2 (10 mg/
kg) > C7070 (10 mg/kg).
The results of the counting the specific number of neu-
ronal nuclei in the inner nuclear layer in the experimental 
groups are presented in Table 7.
From the data obtained, it follows that the neuropro-
tective activity in relation to neurons of the inner nuclear 
layer of the retina is most pronounced in K+C7070 at a 
dose of 10 mg/kg; in C7070 at a dose of 50 mg/kg; and in 
Na+C7070 at a dose of 10 mg/kg.
The results of calculating the “coefficient of change” 
of retinal layers in the experimental groups are presented 
in Table 8.
Thus, based on the complex of obtained histological 
qualitative and quantitative parameters in the experimen-
tal groups, it follows that the studied substances have 
the protective effects when correcting retinal ischemic 
injuries (in descending order): potassium salt of C7070 
(10 mg/kg), C7070 (50 mg/kg) > sodium salt of C7070 
(10 mg/kg) > C7070CO2 (10 mg/kg), C7070 (10 mg/kg).
The results of a complex analysis, including the in-
tegral semi-quantitative assessment of changes in the 
eye fundus during ophthalmoscopy, measurement of the 
microcirculation level in the retina, electroretinography 
and quantitative assessment of the functional state of the 
retina, the results of the histological and morphometric 
studies after 72 hours of reperfusion after a long ischemic 
episode in the retina, make it possible to conclude that 
potassium salt of С7070 at a dose of 10 mg/kg has the 
most pronounced retinoprotective action comparable to 
that of the reference substance C7070 at a dose of 50 mg/
kg, when correcting retinal ischemia-reperfusion in Wis-
Table 3. Influence of Potassium Salt of С7070; Sodium Salt of 
С7070; C7070 Processed with CO2 and С7070 on the Results 
of Semi-quantitative Assessment of Changes in the Eye Fundus 
When Correcting Retinal Ischemic Injury (M ± m; n = 10), points.
Experimental groups Score
1. Intact 0.2 ± 0.2
2. Simulated retinal ischemia-reperfusion 2.8 ± 0.3*
3. Correction by K+C7070, 10 mg/kg 0.2 ± 0.2у
4. Correction by Na+C7070, 10 mg/kg 0.8 ± 0.2*у
5. Correction by С7070CO2, 10 mg/kg 1.4 ± 0.3*у 
6. Correction by С7070, 10 mg/kg 1.2 ± 0.1*у 
7. Correction by С7070, 50 mg/kg 0.4 ± 0.2у
8. Correction by K+C7070, 10 mg/kg + glibenclamide, 5 mg/kg 1.1 ± 0.1*у
9. Correction by Na+C7070, 10 mg/kg + glibenclamide, 5 mg/kg 1.2 ± 0.2*у
10. Correction by С7070CO2, 10 mg/kg + glibenclamide, 5 mg/kg 2.7 ± 0.2* 
11. Correction by С7070, 10 mg/kg + glibenclamide, 5 mg/kg 2.8 ± 0.2*
12. Correction by С7070, 50 mg/kg + glibenclamide, 5 mg/kg 2.5 ± 0.3*
Note: * – p < 0.05 in comparison to the intact group; у – p < 0.05 in comparison to 
the group with pathology simulation.
Table 4. Influence of Potassium Salt of С7070; Sodium Salt of 
С7070; C7070 processed with CO2; C7070 on the Level of Ret-
inal Microcirculation When Correcting Retinal Ischemic Injury 
(M ± m), perfusion units.
Experimental groups Microcirculation level. PU
1. Intact 743.9 ± 5.0
2. Simulated retinal ischemia-reperfusion 353.3 ± 11.7*
3. Correction by K+C7070, 10 mg/kg 732.7 ± 16.9у
4. Correction by Na+C7070, 10 mg/kg 602.1 ± 15.0*у
5. Correction by С7070CO2, 10 mg/kg 398.2 ± 11.6*у
6. Correction by С7070, 10 mg/kg 394.1 ± 9.2*у 
7. Correction by С7070, 50 mg/kg 740.6 ± 12.1у 
8. Correction by K+C7070, 10 mg/kg + 
glibenclamide, 5 mg/kg
450.4 ± 14.2*у 
9. Correction by Na+C7070, 10 mg/kg + 
glibenclamide, 5 mg/kg
428.5 ± 13.3*у 
10. Correction by С7070CO2, 10 mg/kg + 
glibenclamide, 5 mg/kg
365.1 ± 10.3*
11. Correction by С7070, 10 mg/kg + 
glibenclamide, 5 mg/kg
354.8 ± 12.1*
12. Correction by С7070, 50 mg/kg + 
glibenclamide, 5 mg/kg
365.2 ± 15.3*
Note: * – p < 0.05 in comparison to the intact group; у – p < 0.05 in comparison to 
the group with pathology simulation.
Table 5. Influence of Potassium Salt of С7070; Sodium Salt 
of С7070; C7070 processed with CO2; C7070 on the a- and 
b-waves Amplitudes When Correcting Retinal Ischemia-reper-
fusion (M ± m; n = 10), mV.
Experimental groups a-wave amplitudes
b-wave 
amplitudes
1. Intact 0.35 ± 0.03 0.88 ± 0.07 у
2. Simulated retinal ischemia-reperfusion 0.37 ± 0.03 0.44 ± 0.03*
3. Correction by K+C7070, 10 mg/kg 0.35 ± 0.02 0.84 ± 0.03у
4. Correction by Na+C7070, 10 mg/kg 0.36 ± 0.02 0.83 ± 0.05у
5. Correction by С7070CO2, 10 mg/kg 0.37 ± 0.03 0.81 ± 0.06у
6. Correction by С7070, 10 mg/kg 0.36 ± 0.02 0.72 ± 0.06у
7. Correction by С7070, 50 mg/kg 0.36 ± 0.03 0.86 ± 0.06у
8. Correction by K+C7070, 10 mg/kg + 
glibenclamide, 5 mg/kg
0.35 ± 0.02 0.70 ± 0.06у
9. Correction by Na+C7070, 10 mg/kg + 
glibenclamide, 5 mg/kg
0.36 ± 0.04 0.65 ± 0.06*у
10. Correction by С7070CO2, 10 mg/kg + 
glibenclamide, 5 mg/kg
0.37 ± 0.02 0.48 ± 0.04*
11. Correction by С7070, 10 mg/kg + 
glibenclamide, 5 mg/kg
0.37 ± 0.04 0.48 ± 0.06*
12. Correction by С7070, 50 mg/kg + 
glibenclamide, 5 mg/kg
0.38 ± 0.04 0.49 ± 0.06*
Note: * – p < 0.05 in comparison to the intact group; у – p < 0.05 in comparison to 
the group with pathology simulation.
Table 6. Influence of Potassium Salt of С7070; Sodium Salt of 
С7070; C7070 Processed with CO2; C7070 on the Value of the 
b/a Coefficient When Correcting Retinal Ischemia-reperfusion 
(M ± m; n = 10), R.U.
Experimental groups b/a
1. Intact 2.51 ± 0.07
2. Simulated retinal ischemia-reperfusion 1.19 ± 0.05*
3. Correction by K+C7070, 10 mg/kg 2.40 ± 0.11у 
4. Correction by Na+C7070, 10 mg/kg 2.31 ± 0.06у 
5. Correction by С7070CO2, 10 mg/kg 2.19 ± 0.09у 
6. Correction by С7070, 10 mg/kg 2.05 ± 0.20*у 
7. Correction by С7070, 50 mg/kg 2.39 ± 0.09у
8. Correction by K+C7070, 10 mg/kg + glibenclamide, 5 mg/kg 2.00 ± 0.12*у 
9. Correction by Na+C7070, 10 mg/kg + glibenclamide, 5 mg/kg 1.81 ± 0.09*
10. Correction by С7070CO2, 10 mg/kg + glibenclamide, 5 mg/kg 1.30 ± 0.09*
11. Correction by С7070, 10 mg/kg + glibenclamide, 5 mg/kg 1.33 ± 0.11*
12. Correction by С7070, 50 mg/kg + glibenclamide, 5 mg/kg 1.29 ± 0.08*
Note: * – p < 0.05 in comparison to the intact group; у – p < 0.05 in comparison to 
the group with pathology simulation.
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tar rats, which is expressed in the adjusting the retinal ves-
sels calibers, eliminating microaneurysm formation and 
haemorrages in the retina, reducing OD edema, reaching 
the target levels of the retinal blood flow, the b-wave 
amplitude and the b/a coefficient, preserving the micro-
structure of the retinal layers, neurons of the inner nuclear 
layer and photoreceptors. Sodium salt of С7070 at a dose 
of 10 mg/kg is inferior to potassium salt of С7070 at a 
dose of 10 mg/kg and С7070 at a dose of 50 mg/kg in 
terms of renoprotective effects in the simulated retinal is-
chemia-reperfusion. The renoprotective action of С7070 
at a dose of 10 mg/kg is comparable with the action of 
С7070 processed with carbon dioxide at a dose of 10 mg/
kg, and according to the results of a complex assessment 
of the degree of ischemic injury correction in the retina in 
the experiment, is inferior to that of sodium salt of С7070.
Injection of glibenclamide in all the groups with cor-
rection of the pathology by the studied substances resulted 
in partial elimination of their positive effects, presumably 
due to the blockade of ATP-dependent potassium chan-
nels, which confirms the involvement of ATP-dependent 
potassium channels in the mechanism of implementing 
the renoprotective action by the imidazoline receptor ag-
onists, most probably of type III, in the simulated retinal 
ischemia-reperfusion.
Ischemic injuries in the retina and optic nerve are linked 
with haemocirculation disorders: systemic (hypertension, 
atherosclerosis, etc.), organ-histological, and microcircu-
latory. Ischemia leads to the accumulation of impaired me-
tabolism products in the retina, which subsequently leads 
to dystrophy, up to atrophy, of the optic nerve, in the first 
place (Huang et al. 2018, Palmhof et al. 2018).
One of the drugs for specific correction of retinal injuries 
on the background of ischemia may be of imidazoline re-
ceptor ligands of types II and III, the proposed mechanism 
of neuroretinoprotective action of which may be associated 
with inhibition of NMDA receptors in the retina (Han et al. 
2013), inhibition of Na+/H+ ion-exchangers in retinal neu-
rons (type II) (Ernsberger 1999), and activation of ATP-de-
pendent potassium channels (type III) (Morgan and Chan 
2001). The fragments of a hypothetical mechanism for the 
implementation of retinoprotective effects of imidazoline 
receptor agonists: potassium salt of С7070; sodium salt of 
С7070; C7070 processed with CO2; С7070 on the model of 
retinal ischemia-reperfusion is presented in Figure 3.
Table 7. Influence of Potassium Salt of С7070; Sodium Salt of 
С7070; C7070 Processed with CO2; C7070 on the Specific Num-
ber of Neuronal Nuclei in the Inner Nuclear Layer When Correct-
ing Retinal Ischemia-reperfusion (M ± m; n = 10), absolute units.
Experimental groups Specific number of neuronal nuclei
1. Intact 12.2 ± 0.8у
2. Simulated retinal ischemia-reperfusion 6.3 ± 0.6*
3. Correction by K+C7070, 10 mg/kg 11.9 ± 0.8у
4. Correction by Na+C7070, 10 mg/kg 11.0 ± 0.7у
5. Correction by С7070CO2, 10 mg/kg 8.6 ± 0.5*у
6. Correction by С7070, 10 mg/kg 8.1 ± 0.4*у 
7. Correction by С7070, 50 mg/kg 11.4 ± 0.8у
8. Correction by K+C7070, 10 mg/kg + glibenclamide, 
5 mg/kg
10.5 ± 0.6у
9. Correction by Na+C7070, 10 mg/kg + 
glibenclamide, 5 mg/kg
9.4 ± 0.5*у
10. Correction by С7070CO2, 10 mg/kg + 
glibenclamide, 5 mg/kg
7.0 ± 0.5*
11. Correction by С7070, 10 mg/kg + glibenclamide, 
5 mg/kg
6.5 ± 0.6*
12. Correction by С7070, 50 mg/kg + glibenclamide, 
5 mg/kg
7.3 ± 0.5*
Note: * – p < 0.05 in comparison to the intact group; у – p < 0.05 in comparison to 
the group with pathology simulation.
Table 8. Influence of Potassium Salt of С7070; Sodium Salt of 
С7070; C7070 Processed with CO2; C7070 on the “Coefficient 
of Change” of Retinal Layers When Correcting Retinal Isch-
emia-reperfusion (M ± m; n = 10), points.
Experimental groups
Coefficient of change
Photoreceptor Inner nuclear Ganglionic and 
nerve fibres
1. Intact 0.1 ± 0.1у 0.1 ± 0.1у 0.2 ± 0.1у
2. Simulated retinal 
ischemia-reperfusion 1.9 ± 0.3* 2.8 ± 0.2* 2.9 ± 0.2*
3. Correction by 
K+C7070, 10 mg/kg 0.4 ± 0.1
у 0.2 ± 0.1у 1.7 ± 0.1*у
4. Correction by 
Na+C7070, 10 mg/kg 0.8 ± 0.1
у 0.5 ± 0.1у 1.9 ± 0.2*у
5. Correction by 
С7070CO2, 10 mg/kg
1.4 ± 0.2* 2.2 ± 0.2* 2.6 ± 0.2*
6. Correction by С7070, 
10 mg/kg 1.2 ± 0.1* 2.0 ± 0.2* 2.5 ± 0.2*
7. Correction by С7070, 
50 mg/kg 0.4 ± 0.1
у 0.3 ± 0.1у 1.5 ± 0.1*у
8. Correction by 
K+C7070, 10 mg/kg + 
glibenclamide, 5 mg/kg
0.6 ± 0.2у 0.5 ± 0.1у 2.1 ± 0.2*
9. Correction by 
Na+C7070, 10 mg/kg + 
glibenclamide, 5 mg/kg
0.6 ± 0.1у 0.7 ± 0.1у 2.3 ± 0.1*
10. Correction by 
С7070CO2, 10 mg/kg + 
glibenclamide, 5 mg/kg
1.7 ± 0.2* 2.6 ± 0.2* 2.8 ± 0.1*
11. Correction by 
С7070, 10 mg/kg + 
glibenclamide, 5 mg/kg
1.9 ± 0.2* 2.8 ± 0.2* 2.9 ± 0.1*
12. Correction by 
С7070, 50 mg/kg + 
glibenclamide, 5 mg/kg
1.4 ± 0.2* 2.4 ± 0.3* 2.4 ± 0.1*
Note: * – p < 0.05 in comparison to the intact group; у – p < 0.05 in comparison to 
the group with pathology simulation.
Figure 3. Hypothetical mechanism for the implementation of 
neuroretinoprotective effects of imidazoline receptor agonists: 
potassium salt of С7070; sodium salt of С7070; C7070 processed 
with CO2; С7070 on the model of retinal ischemia-reperfusion.
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Conclusion
The main findings of the study are:
1. Potassium salt of C7070 at a dose of 10 mg/kg has 
a pronounced protective effect comparable to that of 
C7070 at a dose of 50 mg/kg when correcting reti-
nal ischemia-reperfusion, which is expressed in im-
proving at most to reach the normal eye fundus im-
age; reaching the target values of blood flow in the 
retina and the b/a coefficient; preserving the micro-
structure of retinal neurons and reaching the norm 
of the specific number of neuronal nuclei in the in-
ner nuclear layer and the ”coefficient of change” of 
the photoreceptor layer and the inner nuclear layer.
2. Sodium salt of С7070 at a dose of 10 mg/kg has 
a protective effect when correcting retinal isch-
emia-reperfusion which is inferior to that of potas-
sium salt of С7070 at a dose of 10 mg/kg, which is 
expressed in a significant 71% decrease (p < 0.05) 
of the integral semi-quantitative assessment of the 
changes in the eye fundus during ophthalmoscopy 
in comparison with the mean value of the group 
without correction; a 70.4% increase in the reti-
nal blood flow level (p < 0.05), a 94% increase in 
the b/a coefficient (p < 0.05) in comparison with 
group without correction; approaching the norm of 
the specific number of neuronal nuclei in the inner 
nuclear layer and the ”coefficient of change” of the 
photoreceptor layer and the inner nuclear layer.
3. According to the results of a complex assessment of 
the degree of correction of retinal ischemic injuries in 
the experiment, the retinoprotective action of С7070 
processed with carbon dioxide at a dose of 10 mg/
kg is inferior to that of sodium and potassium salts 
of С7070, which is expressed in the presence of mi-
croaneurysms and vascular changes in the eye fundus; 
no improvement in the microcirculation level in the 
retina. The b/a coefficient in the group increased by 
84% (p < 0.05) in comparison with the group without 
correction. The specific number of neuronal nuclei in 
the inner nuclear layer increased by 37% (p < 0.05) 
in comparison with the group without correction, 
and was also significantly different from the mean 
of the group of the intact animals. The “coefficient 
of change” of the photoreceptor, inner nuclear and 
ganglion layers did not differ significantly from the 
corresponding values in the group without correction.
4. According to the results of a complex assessment of 
the degree of correction of retinal ischemic injury in 
the experiment, from the comparative perspective, the 
neuroretinoprotective activity of the studied imidaz-
oline receptor agonists is expressed in following de-
scending order: potassium salt of С7070 (10 mg/kg) 
≈ С7070 (50 mg/kg) > sodium salt of С7070 (10 mg/
kg) > С7070 processed with CO2 ≈ С7070 (10 mg/kg).
5. Injection of glibenclamide at a dose of 5 mg/kg in 
the groups with correction of retinal ischemia-reper-
fusion by the studied non-selective imidazoline re-
ceptor agonists at the studied doses leveled their 
neuroretinoprotective effects to different extents, 
which confirms the involvement of ATP-dependent 
potassium channels in the implementation of these 
effects. Presumably, type III imidazoline receptors 
are ATP-dependent potassium channels in the ves-
sels and neurons of the retina.
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